392 related articles for article (PubMed ID: 28705686)
1. Imaging Features of Patients Undergoing Active Surveillance for Ductal Carcinoma in Situ.
Grimm LJ; Ghate SV; Hwang ES; Soo MS
Acad Radiol; 2017 Nov; 24(11):1364-1371. PubMed ID: 28705686
[TBL] [Abstract][Full Text] [Related]
2. Stereotactic and sonographic large-core biopsy of nonpalpable breast lesions: results of the Radiologic Diagnostic Oncology Group V study.
Fajardo LL; Pisano ED; Caudry DJ; Gatsonis CA; Berg WA; Connolly J; Schnitt S; Page DL; McNeil BJ;
Acad Radiol; 2004 Mar; 11(3):293-308. PubMed ID: 15035520
[TBL] [Abstract][Full Text] [Related]
3. Is breast magnetic resonance imaging (MRI) useful for diagnosis of additional sites of disease in patients recently diagnosed with pure ductal carcinoma in situ (DCIS)?
Benveniste AP; Ortiz-Perez T; Ebuoma LO; Sepulveda KA; Severs FJ; Roark A; Wang T; Sedgwick EL
Eur J Radiol; 2017 Nov; 96():74-79. PubMed ID: 29103479
[TBL] [Abstract][Full Text] [Related]
4. Do LORIS Trial Eligibility Criteria Identify a Ductal Carcinoma In Situ Patient Population at Low Risk of Upgrade to Invasive Carcinoma?
Pilewskie M; Stempel M; Rosenfeld H; Eaton A; Van Zee KJ; Morrow M
Ann Surg Oncol; 2016 Oct; 23(11):3487-3493. PubMed ID: 27172775
[TBL] [Abstract][Full Text] [Related]
5. Surgical biopsy is still necessary for BI-RADS 4 calcifications found on digital mammography that are technically too faint for stereotactic core biopsy.
Jeffries DO; Neal CH; Noroozian M; Joe AI; Pinsky RW; Goodsitt MM; Helvie MA
Breast Cancer Res Treat; 2015 Dec; 154(3):557-61. PubMed ID: 26589316
[TBL] [Abstract][Full Text] [Related]
6. Predictors of invasive disease in breast cancer when core biopsy demonstrates DCIS only.
Dillon MF; McDermott EW; Quinn CM; O'Doherty A; O'Higgins N; Hill AD
J Surg Oncol; 2006 Jun; 93(7):559-63. PubMed ID: 16705731
[TBL] [Abstract][Full Text] [Related]
7. Cancelled stereotactic biopsy of calcifications not seen using the stereotactic technique: do we still need to biopsy?
Brennan SB; D'Alessio D; Liberman L; Giri D; Brogi E; Morris EA
Eur Radiol; 2014 Apr; 24(4):907-12. PubMed ID: 24217642
[TBL] [Abstract][Full Text] [Related]
8. Mixed-Methods Study to Predict Upstaging of DCIS to Invasive Disease on Mammography.
Grimm LJ; Neely B; Hou R; Selvakumaran V; Baker JA; Yoon SC; Ghate SV; Walsh R; Litton TP; Devalapalli A; Kim C; Soo MS; Hyslop T; Hwang ES; Lo JY
AJR Am J Roentgenol; 2021 Apr; 216(4):903-911. PubMed ID: 32783550
[No Abstract] [Full Text] [Related]
9. Atypical ductal hyperplasia: Our experience in the management and long term clinical follow-up in 71 patients.
Latronico A; Nicosia L; Faggian A; Abbate F; Penco S; Bozzini A; Cannataci C; Mazzarol G; Cassano E
Breast; 2018 Feb; 37():1-5. PubMed ID: 29032282
[TBL] [Abstract][Full Text] [Related]
10. Radial scars diagnosed on breast core biopsy: Frequency of atypia and carcinoma on excision and implications for management.
Donaldson AR; Sieck L; Booth CN; Calhoun BC
Breast; 2016 Dec; 30():201-207. PubMed ID: 27371970
[TBL] [Abstract][Full Text] [Related]
11. A retrospective alternative for active surveillance trials for ductal carcinoma in situ of the breast.
Van Bockstal MR; Agahozo MC; Koppert LB; van Deurzen CHM
Int J Cancer; 2020 Mar; 146(5):1189-1197. PubMed ID: 31018242
[TBL] [Abstract][Full Text] [Related]
12. A mass on breast imaging predicts coexisting invasive carcinoma in patients with a core biopsy diagnosis of ductal carcinoma in situ.
King TA; Farr GH; Cederbom GJ; Smetherman DH; Bolton JS; Stolier AJ; Fuhrman GM
Am Surg; 2001 Sep; 67(9):907-12. PubMed ID: 11565774
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of breast MRI for surgical decision in patients with breast cancer: ductal carcinoma in situ versus invasive ductal carcinoma.
Lee J; Jung JH; Kim WW; Park CS; Lee RK; Kim HJ; Kim WH; Park HY
BMC Cancer; 2020 Sep; 20(1):934. PubMed ID: 32993586
[TBL] [Abstract][Full Text] [Related]
14. Contrast-Enhanced Digital Mammography in the Surgical Management of Breast Cancer.
Ali-Mucheru M; Pockaj B; Patel B; Pizzitola V; Wasif N; Stucky CC; Gray R
Ann Surg Oncol; 2016 Dec; 23(Suppl 5):649-655. PubMed ID: 27638679
[TBL] [Abstract][Full Text] [Related]
15. Impact of breast MRI in women eligible for breast conservation surgery and intra-operative radiation therapy.
Paudel N; Bethke KP; Wang LC; Strauss JB; Hayes JP; Donnelly ED
Surg Oncol; 2018 Mar; 27(1):95-99. PubMed ID: 29549911
[TBL] [Abstract][Full Text] [Related]
16. Predictive values of BI-RADS(®) magnetic resonance imaging (MRI) in the detection of breast ductal carcinoma in situ (DCIS).
Badan GM; Piato S; Roveda D; de Faria Castro Fleury E
Eur J Radiol; 2016 Oct; 85(10):1701-1707. PubMed ID: 27666605
[TBL] [Abstract][Full Text] [Related]
17. Subclinical ductal carcinoma in situ of the breast. Treatment by local excision and surveillance alone.
Schwartz GF; Finkel GC; Garcia JC; Patchefsky AS
Cancer; 1992 Nov; 70(10):2468-74. PubMed ID: 1330281
[TBL] [Abstract][Full Text] [Related]
18. Surgical Upstaging Rates for Vacuum Assisted Biopsy Proven DCIS: Implications for Active Surveillance Trials.
Grimm LJ; Ryser MD; Partridge AH; Thompson AM; Thomas JS; Wesseling J; Hwang ES
Ann Surg Oncol; 2017 Nov; 24(12):3534-3540. PubMed ID: 28795370
[TBL] [Abstract][Full Text] [Related]
19. Sentinel lymph node biopsy is not necessary in patients diagnosed with ductal carcinoma in situ of the breast by stereotactic vacuum-assisted biopsy.
Kotani H; Yoshimura A; Adachi Y; Ishiguro J; Hisada T; Ichikawa M; Gondou N; Hattori M; Kondou N; Sawaki M; Fujita T; Iwata H
Breast Cancer; 2016 Mar; 23(2):190-4. PubMed ID: 24989112
[TBL] [Abstract][Full Text] [Related]
20. Application of deep learning on mammographies to discriminate between low and high-risk DCIS for patient participation in active surveillance trials.
Alaeikhanehshir S; Voets MM; van Duijnhoven FH; Lips EH; Groen EJ; van Oirsouw MCJ; Hwang SE; Lo JY; Wesseling J; Mann RM; Teuwen J;
Cancer Imaging; 2024 Apr; 24(1):48. PubMed ID: 38576031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
